Walter Olesiak

Walter Olesiak General Information

Biography

Mr. Walter Olesiak serves as Operating Partner at Remiges Ventures. Mr. Olesiak serves as a Board Observer at ENB Therapeutics. He serves as Board Member at OMEICOS Therapeutics. He serves as a Board Observer at Glycomine. Previously, he served as an Investment Partner at Mitsui Global Investment. Most recently he was a Director with Cambridge Pharma Consultancy where he worked with pharmaceutical and biotech clients to address issues of market access for new products and technologies, to ensure consideration of the commercial value of products in strategic planning and to guide development of pricing and reimbursement strategies specific to the dynamics of different country markets. Prior to Cambridge, he spent close to ten years in Japan, initially with Genzyme Japan and later with SRL Incorporated. During his tenure in Japan he had responsibilities spanning business development, corporate strategy, contract negotiation and corporate partnering. He served as Board Member at Stromatis Pharma. Mr. Olesiak has over 28 years' experience in business development, healthcare consulting and venture investment. He has spent 12 years in venture investments with Mitsui Ventures, during which time he held positions as a board member or observer in 10 portfolio companies. Prior to Mitsui, Walter spent 6 years with Cambridge Pharma Consultancy (an IMS Health company) advising on global pharmaceutical pricing, reimbursement and market access issues to leading pharmaceutical and biotechnology companies. Prior to Cambridge, Walter spent 8 years in Tokyo in various roles with Genzyme Japan and SRL, Inc. Walter holds a AB in Biochemical Sciences from Harvard University and MBA from Cornell University.